Bioelectronic Medicine & Neurostimulation
SetPoint Medical
by SetPoint Medical Corporation
Implantable vagus nerve stimulator harnessing the inflammatory reflex to treat rheumatoid arthritis
Category
Bioelectronic Medicine & Neurostimulation
Founded
2010
Headquarters
Valencia, CA, USA
Overview
SetPoint Medical is a bioelectronic medicine company developing an implantable vagus nerve stimulation device to treat chronic inflammatory diseases by activating the body's natural anti-inflammatory reflex — the cholinergic anti-inflammatory pathway. The company's miniaturized implant is placed at the cervical vagus nerve via a minimally invasive surgical procedure and delivers precisely calibrated electrical pulses that activate sensory and motor fibers communicating with the spleen and immune system. This neural-immune circuit suppresses cytokine production — including TNF-alpha, IL-6, and IL-1 — providing disease modification without systemic immunosuppression. Rheumatologists and their patients with rheumatoid arthritis (RA) who have inadequate response to conventional biologics and JAK inhibitors are SetPoint Medical's primary target population. The RESET-RA pivotal trial demonstrated statistically significant improvement in disease activity scores and clinical response rates compared to sham stimulation, supporting the FDA Breakthrough Device designation received in 2018. Beyond RA, the company's pipeline targets inflammatory bowel disease and other conditions where TNF-alpha and IL-6 drive pathology. SetPoint Medical's bioelectronic approach differs fundamentally from pharmaceutical immunosuppression: rather than continuously flooding the body with drug molecules that suppress the immune system globally, it activates a localized neural circuit that triggers a physiological, self-limiting anti-inflammatory response only when stimulation is applied. This on-demand mechanism may reduce infection risk and other immunosuppression complications that limit long-term biologic use. The company is backed by GlaxoSmithKline's Galvani Bioelectronics venture and has raised over $200 million from health-focused investors including Action Potential Venture Capital.
Key Features
Miniaturized Implantable Devices
Ultra-small implantable neurostimulators for precise modulation of specific neural circuits.
Closed-Loop Therapy
Real-time adjustment of stimulation parameters based on continuous physiological feedback.
Targeted Nerve Stimulation
Precise electrical stimulation of specific nerve targets to treat chronic conditions without drugs.
Long-Term Safety Monitoring
Continuous monitoring of device performance and tissue interface health over years.
Patient Remote Monitoring
Remote monitoring of therapy delivery and patient outcomes via mobile applications.
Pros & Cons
Pros
- +Non-invasive neurostimulation options provide therapeutic benefits without surgical implantation
- +AI-driven patient-specific stimulation patterns optimize treatment outcomes
- +Clinical evidence supports efficacy for chronic pain, depression, epilepsy, and inflammatory disorders
- +Reduced drug dependency through bioelectronic alternatives to chronic pharmaceutical treatments
- +Targeted nerve stimulation treats chronic conditions without pharmaceutical side effects
- +Closed-loop systems adjust stimulation parameters in real-time based on physiological feedback
Cons
- −Mechanism of action not fully understood for many neurostimulation therapeutic applications
- −Long-term safety and efficacy data for novel neurostimulation approaches remains limited
- −Patient variability in nerve anatomy creates challenges for consistent treatment outcomes
- −Device implantation requires specialized surgical expertise not widely available
- −Battery life limitations may necessitate replacement procedures for implantable devices
Use Cases
Research Workflow Optimization
AI-powered optimization of research workflows to accelerate discovery timelines and improve reproducibility.
Data Analysis & Insights
Machine learning analysis of complex biological datasets to extract actionable insights and identify patterns.
Collaboration & Knowledge Management
Platform-enabled collaboration across distributed research teams with integrated data sharing and knowledge capture.